(VRCA) – Downgrades
-
Needham & Company Downgrades Verrica Pharmaceuticals (VRCA) to Hold, Removes Price Target on "Uncertain Delay", Reiterates that "Ycanth Has a Bright Commercial Future"
-
UPDATE: Needham & Company Downgrades Verrica Pharmaceuticals (VRCA) to Hold
-
-
Back to VRCA Stock Lookup